New research reveals a potentially effective COVID-19 pill is in the works. Here’s what infectious disease experts want you ...
4don MSN
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds
The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after ...
Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...
An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...
An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, ...
The worst damage from COVID-19 was first measured in fevers, oxygen levels and death counts. Now, years later, researchers ...
Dr. Pappas can be contacted at [email protected]. This letter was published on July 9, 2025, at NEJM.org. No potential conflict of interest relevant to this letter was reported. Zhang B, Thacker D, ...
11don MSN
From Ebola to COVID-19: History of infectious disease treatment at UNMC and Nebraska Medicine
Nebraska Medicine and the University of Nebraska Medical Center have a history of treating patients in past global disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results